TPST financials

Tempest Therapeutics (TPST) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

TPST income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$26.57M-$26.26M-6.33
2024––-$42.03M-$41.84M-19.50
2023––-$29.16M-$29.49M-24.83
2022––-$34.64M-$35.71M-40.17
2021––-$26.99M-$28.30M-97.11
2020––-$19.30M-$19.21M-533.39